CRP-话题@MedSci

#CRP#

84篇内容 | 1788人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2199517, encodeId=d2b8219951e6c, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a> <a href='/topic/show?id=9bbd914264' target=_blank style='color:#2F92EE;'>#hsCRP#</a>, objectTitle=解读C反应蛋白(CRP)与超敏C反应蛋白(hsCRP)的区别？, objectType=article, longId=821731, objectId=8641821e3192, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679868140278_4754896.png, objectUrl=/article/show_article.do?id=8641821e3192, replyNumber=0, likeNumber=4, createdTime=2024-04-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=8641821e3192, moduleTitle=解读C反应蛋白(CRP)与超敏C反应蛋白(hsCRP)的区别？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8641821e3192)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2179378, encodeId=6f5921e9378a8, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a> <a href='/topic/show?id=625a10962ea2' target=_blank style='color:#2F92EE;'>#不可切除肝细胞癌(HCC)#</a>, objectTitle=Hepatol Res：C-反应蛋白在接受阿替利珠单抗和贝伐珠单抗治疗的不可切除肝细胞癌患者中的预后意义, objectType=article, longId=808203, objectId=a6e38082036d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=a6e38082036d, replyNumber=0, likeNumber=20, createdTime=2024-01-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a6e38082036d, moduleTitle=Hepatol Res：C-反应蛋白在接受阿替利珠单抗和贝伐珠单抗治疗的不可切除肝细胞癌患者中的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6e38082036d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1269640, encodeId=498c1269640eb, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=PCT（降钙素原）与CRP（C-反应蛋白）的临床应用, objectType=article, longId=738911, objectId=efdfe3891159, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efdfe3891159, replyNumber=0, likeNumber=44, createdTime=2022-09-12, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efdfe3891159, moduleTitle=PCT（降钙素原）与CRP（C-反应蛋白）的临床应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efdfe3891159)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269639, encodeId=fea5126963981, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=一文读懂CRP、hs-CRP、WBC的关系及结果相互不匹配的问题, objectType=article, longId=738304, objectId=a3ade383042c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3ade383042c, replyNumber=0, likeNumber=46, createdTime=2022-09-07, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3ade383042c, moduleTitle=一文读懂CRP、hs-CRP、WBC的关系及结果相互不匹配的问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3ade383042c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269637, encodeId=6678126963e6c, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=Annals Neurology-血浆MIA、CRP和白蛋白，预示着帕金森病的认知能力下降, objectType=article, longId=733036, objectId=353ae3303677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=353ae3303677, replyNumber=0, likeNumber=50, createdTime=2022-07-24, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=353ae3303677, moduleTitle=Annals Neurology-血浆MIA、CRP和白蛋白，预示着帕金森病的认知能力下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=353ae3303677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269636, encodeId=701e12696365b, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=CRP、血脂四项只用来看感染和高脂血症？组合使用竟可预示癌症患者结局！, objectType=article, longId=731022, objectId=bb66e310221f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb66e310221f, replyNumber=0, likeNumber=64, createdTime=2022-07-03, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb66e310221f, moduleTitle=CRP、血脂四项只用来看感染和高脂血症？组合使用竟可预示癌症患者结局！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb66e310221f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269635, encodeId=a93f126963585, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=一文读懂！CRP、hs-CRP、WBC的关系及结果相互不匹配的问题, objectType=article, longId=302135, objectId=400a30213505, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=400a30213505, replyNumber=0, likeNumber=43, createdTime=2022-04-02, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=400a30213505, moduleTitle=一文读懂！CRP、hs-CRP、WBC的关系及结果相互不匹配的问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=400a30213505)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269634, encodeId=1d9d126963439, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=血常规和C反应蛋白(CRP)联合应用结果判读, objectType=article, longId=300697, objectId=80a630069e2f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80a630069e2f, replyNumber=0, likeNumber=48, createdTime=2022-03-15, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80a630069e2f, moduleTitle=血常规和C反应蛋白(CRP)联合应用结果判读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80a630069e2f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269633, encodeId=698f126963370, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=Target Oncol:真实世界评估阿比特龙+泼尼松或泼尼松龙(AAP)一线或二线治疗转移性去势抵抗前列腺癌(mCRPC)的疗效和安全性, objectType=article, longId=299289, objectId=97bb29928916, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97bb29928916, replyNumber=0, likeNumber=42, createdTime=2022-02-22, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97bb29928916, moduleTitle=Target Oncol:真实世界评估阿比特龙+泼尼松或泼尼松龙(AAP)一线或二线治疗转移性去势抵抗前列腺癌(mCRPC)的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97bb29928916)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269632, encodeId=3c09126963225, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=Alzheimer&Dementia：外周血CRP水平越低，老年痴呆风险越高！, objectType=article, longId=295180, objectId=5ee2295180a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ee2295180a1, replyNumber=0, likeNumber=48, createdTime=2022-02-07, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ee2295180a1, moduleTitle=Alzheimer&Dementia：外周血CRP水平越低，老年痴呆风险越高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ee2295180a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269631, encodeId=def6126963116, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=9项建议：SAA单独和与CRP联合检测在儿童感染性疾病中的应用专家共识, objectType=article, longId=293762, objectId=a841293e6271, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a841293e6271, replyNumber=0, likeNumber=41, createdTime=2022-01-12, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a841293e6271, moduleTitle=9项建议：SAA单独和与CRP联合检测在儿童感染性疾病中的应用专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a841293e6271)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269630, encodeId=b48912696301d, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=Eur J Cancer：Nivolumab联合多西他赛治疗未经化疗的转移性去势抵抗前列腺癌(mCRPC)的疗效和安全性, objectType=article, longId=221438, objectId=433422143891, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=433422143891, replyNumber=0, likeNumber=33, createdTime=2021-12-04, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=433422143891, moduleTitle=Eur J Cancer：Nivolumab联合多西他赛治疗未经化疗的转移性去势抵抗前列腺癌(mCRPC)的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=433422143891)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269629, encodeId=02b2126962944, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=Cardiovasc Diabetol：在2型糖尿病患者中，hs-CRP是心血管事件和全因死亡率的危险因素, objectType=article, longId=220646, objectId=be5c220646c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be5c220646c5, replyNumber=0, likeNumber=53, createdTime=2021-11-21, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be5c220646c5, moduleTitle=Cardiovasc Diabetol：在2型糖尿病患者中，hs-CRP是心血管事件和全因死亡率的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be5c220646c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269638, encodeId=1572126963822, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=检验项目 | 风湿四项：ASO、RF、CRP、CCP的临床意义, objectType=article, longId=277066, objectId=eb2b2e706600, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb2b2e706600, replyNumber=0, likeNumber=0, createdTime=2021-11-10, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb2b2e706600, moduleTitle=检验项目 | 风湿四项：ASO、RF、CRP、CCP的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb2b2e706600)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269628, encodeId=071712696282e, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=Lancet Oncol：阿帕鲁胺联合阿比特龙-泼尼松可明显改善mCRPC患者的生存预后, objectType=article, longId=218148, objectId=fdff218148d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdff218148d4, replyNumber=0, likeNumber=52, createdTime=2021-10-07, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdff218148d4, moduleTitle=Lancet Oncol：阿帕鲁胺联合阿比特龙-泼尼松可明显改善mCRPC患者的生存预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdff218148d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269627, encodeId=3501126962ee4, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=EU：评估哪些mCRPC患者更适合阿比特龙的模型, objectType=article, longId=217639, objectId=674a21e639d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=674a21e639d1, replyNumber=0, likeNumber=54, createdTime=2021-09-26, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=674a21e639d1, moduleTitle=EU：评估哪些mCRPC患者更适合阿比特龙的模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=674a21e639d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269626, encodeId=aabe1269626f1, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=Clin Cancer Res：遗憾！阿特珠单抗+镭-223联合方案未能给mCRPC患者带来额外的临床效益, objectType=article, longId=216703, objectId=fd7e216e0320, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd7e216e0320, replyNumber=0, likeNumber=38, createdTime=2021-09-06, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd7e216e0320, moduleTitle=Clin Cancer Res：遗憾！阿特珠单抗+镭-223联合方案未能给mCRPC患者带来额外的临床效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd7e216e0320)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269625, encodeId=8951126962594, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=Cancers：结直肠癌（CRC）患者辅助化疗后血浆中CEA, CA19-9, IL-6, CRP,和 YKL-40水平预测疾病进展的提前时间和预后作用, objectType=article, longId=215266, objectId=4d022152664b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d022152664b, replyNumber=0, likeNumber=0, createdTime=2021-08-05, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d022152664b, moduleTitle=Cancers：结直肠癌（CRC）患者辅助化疗后血浆中CEA, CA19-9, IL-6, CRP,和 YKL-40水平预测疾病进展的提前时间和预后作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d022152664b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269624, encodeId=651c1269624d3, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=Stroke：机器学习算法明显提高CRP水平预测蛛网膜下腔出血预后的准确性, objectType=article, longId=214275, objectId=71792142e580, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71792142e580, replyNumber=0, likeNumber=35, createdTime=2021-07-17, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71792142e580, moduleTitle=Stroke：机器学习算法明显提高CRP水平预测蛛网膜下腔出血预后的准确性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71792142e580)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269623, encodeId=334d126962326, content=<a href='/topic/show?id=ca6952e52f' target=_blank style='color:#2F92EE;'>#CRP#</a>, objectTitle=Eur J Cancer：耄耋之年mCRPC患者采用恩杂鲁胺治疗的效果优于醋酸阿比特龙, objectType=article, longId=212999, objectId=791f2129998e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=791f2129998e, replyNumber=0, likeNumber=52, createdTime=2021-06-22, rootId=0, userName=rebeccajiejie, userId=e1cc90, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=791f2129998e, moduleTitle=Eur J Cancer：耄耋之年mCRPC患者采用恩杂鲁胺治疗的效果优于醋酸阿比特龙, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=791f2129998e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CRP

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#CRP# #hsCRP#

解读C反应蛋白(CRP)与超敏C反应蛋白(hsCRP)的区别？

2024-04-20发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#CRP# #不可切除肝细胞癌(HCC)#

Hepatol Res：C-反应蛋白在接受阿替利珠单抗和贝伐珠单抗治疗的不可切除肝细胞癌患者中的预后意义

2024-01-05发表于上海

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

PCT（降钙素原）与CRP（C-反应蛋白）的临床应用

2022-09-12

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

一文读懂CRP、hs-CRP、WBC的关系及结果相互不匹配的问题

2022-09-07

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

Annals Neurology-血浆MIA、CRP和白蛋白，预示着帕金森病的认知能力下降

2022-07-24

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

CRP、血脂四项只用来看感染和高脂血症？组合使用竟可预示癌症患者结局！

2022-07-03

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

一文读懂！CRP、hs-CRP、WBC的关系及结果相互不匹配的问题

2022-04-02

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

血常规和C反应蛋白(CRP)联合应用结果判读

2022-03-15

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

Target Oncol:真实世界评估阿比特龙+泼尼松或泼尼松龙(AAP)一线或二线治疗转移性去势抵抗前列腺癌(mCRPC)的疗效和安全性

2022-02-22

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

Alzheimer&Dementia：外周血CRP水平越低，老年痴呆风险越高！

2022-02-07

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

9项建议：SAA单独和与CRP联合检测在儿童感染性疾病中的应用专家共识

2022-01-12

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

Eur J Cancer：Nivolumab联合多西他赛治疗未经化疗的转移性去势抵抗前列腺癌(mCRPC)的疗效和安全性

2021-12-04

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

Cardiovasc Diabetol：在2型糖尿病患者中，hs-CRP是心血管事件和全因死亡率的危险因素

2021-11-21

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

检验项目 | 风湿四项：ASO、RF、CRP、CCP的临床意义

2021-11-10

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

Lancet Oncol：阿帕鲁胺联合阿比特龙-泼尼松可明显改善mCRPC患者的生存预后

2021-10-07

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

EU：评估哪些mCRPC患者更适合阿比特龙的模型

2021-09-26

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

Clin Cancer Res：遗憾！阿特珠单抗+镭-223联合方案未能给mCRPC患者带来额外的临床效益

2021-09-06

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

Cancers：结直肠癌（CRC）患者辅助化疗后血浆中CEA, CA19-9, IL-6, CRP,和 YKL-40水平预测疾病进展的提前时间和预后作用

2021-08-05

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

Stroke：机器学习算法明显提高CRP水平预测蛛网膜下腔出血预后的准确性

2021-07-17

rebeccajiejie (审核中...)

前往app查看评论内容

#CRP#

Eur J Cancer：耄耋之年mCRPC患者采用恩杂鲁胺治疗的效果优于醋酸阿比特龙

2021-06-22

科室
- - 订阅+
  - 更多科室
工具
服务